Comparing ARWR and ALNY AAT clinical trials | ARWR Message Board Posts

Arrowhead Pharmaceuticals, Inc.

  ARWR website

ARWR   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  10053 of 10064  at  9/1/2019 6:42:44 PM  by

Steve_382


 In response to msg 10052 by  evernewbliss
view thread

Re: Comparing ARWR and ALNY AAT clinical trials

 I don't know what it means, but it looks like the Alnylam trial is focusing on participants with ZZ type alpha-1 antitrypsin deficiency (PiZZ) and biopsy-proven alpha-1 antitrypsin (AAT) deficiency-associated liver disease. Not sure that's the same group that ARWR is looking at. Didn't see any mention of the ZZ type in the ARWR study. Over my pay grade.
 
Also, it looks like the ALNY P1/2 is supposed to be done in June of 2021, while the ARWR P2/P3 is expected to be done in May of 2023. So, maybe the completion dates are not that much different in reality. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 236
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...